This finding not only expands the understanding of the regulatory mechanisms of epigenetic modification, but also fills the gap in the LEDGF‐driven transcriptional reprogramming mechanisms in SETD2 mutant ccRCC. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.